SCHEMBL5504640

SCHEMBL5504640

[CH2]C1(N2CCOCC2)CN(S(=O)(=O)CCC)C1

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.46
▸ LMNA P02545 2/20 0.46
▸ CYP1A2 P05177 1/20 0.42
▸ CYP2C9 P11712 1/20 0.37
▸ SLC6A9 P48067 8/20 0.36
▸ CA12 O43570 1/20 0.33
▸ CA7 P43166 1/20 0.33
▸ CA14 Q9ULX7 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ GLA P06280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3889138 0.79 ALDH1A1 (0.44) ALDH1A1LMNACYP1A2CYP2C9SLC6A9
SCHEMBL4547019 0.77 ALDH1A1 (0.61) ALDH1A1LMNACYP1A2CYP2C9SLC6A9
SCHEMBL3886476 0.73 SLC6A9 (0.46) ALDH1A1LMNACYP1A2CYP2C9SLC6A9
SCHEMBL1819095 0.70 SLC6A9 (0.39) ALDH1A1LMNASLC6A9L3MBTL1KDM4E
SCHEMBL6277369 0.70 ALDH1A1 (0.56) ALDH1A1LMNACYP1A2SLC6A9GLA
SCHEMBL5501250 0.69 ALDH1A1 (0.41) ALDH1A1LMNACYP1A2CYP2C9SLC6A9
SCHEMBL8278195 0.68 SLC6A9 (0.42) ALDH1A1LMNACYP1A2CYP2C9SLC6A9
SCHEMBL7297373 0.67 ALDH1A1 (0.50) ALDH1A1LMNACYP1A2CA12CA7
SCHEMBL23555007 0.67 L3MBTL1 (0.56) ALDH1A1LMNACYP1A2SMN1; SMN2L3MBTL1
SCHEMBL21210697 0.66 LMNA (0.49) ALDH1A1LMNACYP1A2CA12CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1745018-A1 AZETIDINE GLYCINE TRANSPORTER INHIBITORS Merck & Co., Inc. (US) 2007-01-24 — — EP disclosed
WO-2005110983-A1 AZETIDINE GLYCINE TRANSPORTER INHIBITORS MERCK & CO., INC. (US) 2005-11-24 — — WO disclosed
Send feedback